Related Experiment Video
Updated: Feb 19, 2026

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
[Cardiovascular protective action of Rho-kinase inhibitors]
1Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences.
Insights
The Rho/Rho-kinase pathway is implicated in hypertension and vascular diseases. Inhibiting Rho-kinase may lower vascular resistance and offer cardioprotective benefits for hypertensive patients.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Pharmacology
Background:
- The Rho/Rho-kinase pathway is crucial in the development of hypertensive vascular diseases.
- This pathway contributes to increased vascular resistance and atherosclerotic changes, including inflammation and proliferation.
Purpose of the Study:
- To explore the role of the Rho/Rho-kinase pathway in hypertension.
- To evaluate Rho-kinase as a potential therapeutic target for hypertensive vascular diseases.
Main Methods:
- Review of existing literature on Rho/Rho-kinase pathway in hypertension.
- Analysis of studies investigating Rho-kinase inhibition effects on vascular resistance.
Main Results:
- Rho-kinase pathway inhibition has been shown to reduce elevated vascular resistance in hypertensive patients.
- The pathway's involvement in atherosclerotic changes suggests broader implications.
Conclusions:
- Rho-kinase represents a promising new therapeutic target for hypertension and associated vascular conditions.
- Rho-kinase inhibitors may possess cardioprotective effects, warranting further investigation.
Abstract:
The Rho/Rho-kinase pathway plays an important role in pathophysiology and formation of hypertensive vascular diseases. This pathway contributes to both increased vascular resistance and atherosclerotic changes. The latter includes inflammatory and proliferative changes. In patients with hypertension, inhibition of Rho-kinase has been shown to decrease the increased vascular resistance. Therefore, Rho-kinase will be a new therapeutic target for hypertension and hypertensive vascular diseases. Thus, Rho-kinase inhibitors may have a cardioprotective action.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Direct Renin Inhibitors
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

